Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | Mastering B-cell biomarker tracking in autoimmune therapy 6 days 10 hours 3 mins 46 secs SAVE YOUR SEAT!

Gene therapy R&D roadmap – tools and techniques

18 Nov 2019
An author's perspective General interest

This In the Zone infographic explores the tools and techniques used during the AAV gene therapy development pathway, detailing the neccessary steps during the process; from rAAV generation and in vitro and in vivo testing through to assessing the host immune response.

 


 

itz-gene-therapy-banner

Top content

  • Novartis to acquire Avidity Biosciences in $12B deal to boost RNA therapeutics pipeline
  • AAPS PharmSci 360 2025: what can conference attendees look forward to?
  • Navigating the bioanalytical complexities of oligonucleotide therapeutics

Related tags

Absorption Systems gene therapy in the zone techniques tools
Previous article Next article

Related articles

19 NOV 2024 INTERVIEWS
Shaping gene and cell therapy innovations with bioanalysis: an interview with Boris Gorovits
26 FEB 2019 JOURNAL ARTICLES
2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 – LBA/cell-based assays: immunogenicity, biomarkers and PK assays)
19 JUN 2023 ADVANCED THERAPIES
The new gold standard for gene therapy protein expression potency measurements
30 NOV 2023 CONFERENCE REPORTS
Editor’s highlights from the European Bioanalysis Forum 2023
6 SEP 2019 GENERAL INTEREST
In the Zone: Peptide Bioanalysis Sample Preparation
3 AUG 2023 NEWS
AstraZeneca to purchase Pfizer’s early-stage gene therapies portfolio
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone